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CMR Detects Subclinical
Cardiomyopathy in Mother-
Carriers of Duchenne and
Becker Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is an X-linked reces-
sive disorder, leading to reduced/abnormal dystrophin. Becker
muscular dystrophy (BMD) is a milder form, caused by the
same mutation, with a nearly normal life expectancy, but with
a 50% chance of cardiac involvement (CI) (1). Although
female carriers are usually free of symptoms, they may develop
peripheral myopathy and cardiomyopathy, contributing to
heart failure (HF) (1).
Our aim was to evaluate the possibility of myocardial
damage in genetically confirmed mothers-carriers of Duch-
enne muscular dystrophy (DMDc) and Becker muscular dys-
trophy (BMDc) using cardiac magnetic resonance (CMR).
Thirty-five mothers, mean age 50 years (range: 32 to 68
years), without known comorbidities, except mild hyperten-
sion (systolic blood pressure 160 to 170 mm Hg in 1 DMDc
and 1 BMDc), were studied. DMDc (n  25) and BMDc
(n  10) were prospectively evaluated by CMR using a 1.5-T
General Electric Signa HDxt (Milwaukee, Wisconsin). A
standard steady-state free-precession (SSFP) sequence (FI-
ESTA) (echo time  1.5 ms, repetition time  3.1 ms, flip
angle  70°, slice thickness  8 mm) was used to measure the
eft ventricular ejection fraction (LVEF). To assess fibrosis, 0.2
mol/kg gadolinium diethylenetriamine penta-acetic acid was
dministered, and late gadolinium-enhanced (LGE) images
ere taken 15 min later, using a 3-dimensional–T1-turbo field
cho sequence (flip angle  15°, echo time  1.4 ms,
repetition time  5.5 ms, inversion time 225 to 275 ms as
Figure 1. Late Gadolinium-Enhanced Image of a Becker Muscular
Dystrophy Carrier With Mild Epicardial Fibrosis in the Lateral Wall of the
Left Ventricleindividually optimized to null myocardial signal, gap  0, slice
thickness  6 mm). A threshold of 6 SD exceeding the mean
was used to define LGE images (2). Summing the planimetered
LGE areas in all short-axis slices yielded the total volume,
expressed as a proportion of left ventricular (LV) myocardium
(percentage of LGE).
Measurements were expressed as mean  SD or mean
(range). Statistical significance was investigated by unpaired
Student t test. Correlation was sought with Pearson correla-
tion coefficient. The Mann-Whitney test and Spearman cor-
relation coefficient were used for nonparametric data. Statis-
tical significance was considered p  0.05.
Eight DMDc and 1 BMDc presented with muscle weakness,
recognized by the subjects, but which did not affect daily
activities. Cardiac symptoms were documented only in 5 of 25
DMDc. Creatine kinase (CK) was measured in all carriers. CK
values of 290  120 IU/l (normal values 190 IU/l) were
identified in 15 of 35 (42.8%) carriers (13 [52%] DMDc and 2
[20%] BMDc). CMR documented decreased LVEF in 10
DMDc and subepicardial LGE images in posterolateral and/or
septal LV wall in 18 DMDc and 5 BMDc (Figs. 1 and 2). No
difference in LGE morphology was identified between DMDc
and BMDc. LGE images correlated negatively with LVEF
(p  0.001) and were greater in DMDc compared with BMDc
(16  2% vs. 3  1%, p  0.001, respectively). Carriers 40
years old had more extensive lesions compared with those 40
years old (14  2% vs. 3  1%, p  0.001). The lack of
comorbidities that could be possibly related to CMR findings
strengthens the role of abnormal dystrophin in their pathogenesis.
Carriers’ characteristics are presented in Table 1.
According to previous studies, 12% of BMDc presented
with muscle weakness, and CK was increased in 30% to 62%
(1,3,4). In our study, although some BMDc had muscular
symptoms and increased CK, the majority was asymptomatic
with normal CK. The prevalence of CI on electrocardiography
Figure 2. Late Gadolinium-Enhanced Image of a Duchene Muscular
Dystrophy Carrier With Severe Epicardial Fibrosis in the Lateral Wall of
the Left Ventricle(ECG) and echocardiography and the possibility of dilated
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Letters to the Editor 527cardiomyopathy (dCMP) varied widely (3,4). CI in BMDc appears
after the age of 16 years and may remain subclinical with advancing
age in up to two-thirds of subjects. It can be manifested as ECG
changes in two-fifths or as dCMP in up to one-fifth of cases (3).
Our BMDc findings were in agreement with previous studies
identifying normal ECG and echocardiographic results in the
majority of subjects.
DMDc are more likely to develop dCMP at a young age (3). A
2002 consensus estimated that 10% of all DMDc or BMDc develop
dCMP, even without skeletal muscle involvement (3). However,
the impact of increased dCMP risk on life expectancy is still unclear
(3). Although only a minority of our patients presented with
muscular involvement, some DMDc already had LV impairment
and rhythm disturbances. These findings were in agreement with
previous studies supporting that CI is independent of muscular
disturbances in DMDc (3).
Recently, CMR has been successfully used to identify myocardial
fibrosis in subclinical DMDc or BMDc (4,5). However, except for
case reports (4,5), there are not enough data about CMR in
dystrophinopathy carriers. In our study, we identified myocardial
fibrosis in the majority of carriers, with a significant superiority in
Table 1. DMDc and BMDc Clinical Characteristics and Comorbidities
Age (yrs) (median, range)
Height (cm) (median, range)
Weight (kg) (median, range)
Diabetes mellitus
Hypertension (SBP 160–170 mm Hg)
Dyslipidemia
Smoking
Alcohol consumption
Infections that could possibly induce myocardial damage
Valvular disease
BMI (kg/m2) (median, range)
ECG 1. Nonspeciﬁc
2. Negative T i
24-h ECG recording 1. Sinus tachyc
2. Supraventric
3. Ventricular e
4. Bigeminy (3
5. Couples (2/2
ECHO (LV dysfunction)
CMR (normal LV function)
LVEF 69.4 4.
LVEDV 131.9
LVESV 40.2 1
CMR (LV dysfunction)
LVEF 45.0 2.
LVEDV 186.4
LVESV 107.1
LGE () 18/25 (10 with
Abnormal serum CPK
Values are n, median (range), or mean  SD, unless speciﬁed otherwise.
BMDc Becker muscular dystrophy carriers; BMI body mass index; CMR cardiac magneti
electrocardiography: ECHO  echocardiography; LGE  late gadolinium-enhanced; LV  left v
LVESV  left ventricular end-systolic volume; SBP  systolic blood pressure.severity of DMDc over BMDc and older carriers over youngerarriers. The inverse correlation of fibrotic area, identified by LGE
maging, with LVEF supports the role of fibrosis in the develop-
ent of HF (1,2). Furthermore, CMR proved to be of great
ignificance documenting CI in a percentage higher than that
dentified by routine assessment.
The study limitations were that the population of studied carriers
as small, young female carriers were not included, and long-term
ollow-up was not available.
To conclude, CMR documented myocardial fibrosis in the majority
f dystrophinopathy carriers, although the usual assessment was mildly
bnormal. However, the clinical implications of CMR and the neces-
ity for early cardiac treatment need further evaluation.
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D (n  25) BMD (n  10)
8 (33–65) 52 (31–69)
0 (158–175) 168 (160–172)
0 (62–78) 74 (65–80)
0 0
1/25 1/10
0 0
0 0
0 0
0 0
0 0
3 (18–26) 24 (19–27)
hanges (6/25)
ads V4 to V6 (6/25)
Nonspeciﬁc ST-changes (2/10)
ia (10/25)
extrasystolic beats (10/25)
systolic beats (5/25)
Supraventricular extrasystolic beats (2/10)
6/25 0
15/25
0 ml
ml
10/10
LVEF 70.3 2.5%
LVEDV 174.5 31.3 ml
LVESV 51.0 14.1 ml
10/25
0 ml
ml
0
LVEF/8 with normal LVEF) 5/10 (all with normal LVEF)
3/25 (52%) 2/10 (20%)
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Interval from the Onset of
Transmitral Flow to Annular
Velocity Is a Marker of
LV Filling Pressure
Recently, the time interval between the onset of early diastolic transmitral
flow velocity (E) and mitral annular velocity (e=) (TE-e=) was proposed as
new index representing left ventricular (LV) relaxation. A problem with
hemeasurement of TE-e= was that E and e= could not be measured in the
ame beat. However, a novel dual Doppler echocardiographic method has
een introduced that allows themeasurement of bothE and e= in the same
eat (1), and E/e= and TE-e= can be instantly calculated. The aims of this
tudy were to: 1) investigate the usefulness of single-beat TE-e= compared
with invasive hemodynamic measurements; and 2) determine the impact
of pre-load alterations by leg-positive pressure (LPP) on the relationship
between TE-e= and increased LV filling pressure.
We designed a prospective study to assess 42 consecutive patients
who underwent catheterization for diagnosis of stable angina pectoris.
Twenty-one age- and sex-matched healthy volunteers served as the
control group. Patients with atrial fibrillation, valve diseases, severe
heart failure, LV systolic dysfunction (LV ejection fraction 40%), or
a regional wall motion abnormality at the basal, lateral, or septal region
were excluded.
A total of 63 pairs of echocardiographic examinations were per-
formed at baseline and during LPP. We used an ultrasound machine
EUB-7500 (Hitachi Medical Corporation, Kashiwa, Japan). A 5-F
Millar transducer with single lumen was introduced into the LV. Tau
and LV end-diastolic pressure (LVEDP) were determined from the
LV pressure curve, and measurements were performed simultaneously
with the echocardiographic measurements.We customized a commer-
cially available leg massage machine (Dr. Medomer DM-5000EX,
Medo Industries, Tokyo, Japan) because it could maintain the same
pressure loading (90 mm Hg) for 5 min.
Values are expressed as mean  SD. The diagnostic ability of
echocardiographic parameters to discriminate elevated LVEDP (16
mm Hg) was determined by analysis of receiver-operating character-
istic (ROC) curves. Reproducibility was expressed as the intraclassorrelation coefficients (ICC) in a group of 10 randomly selected
ubjects by 1 observer, and then repeated on 2 separate days by 2
nvestigators.
The clinical characteristics and the influence of LPP in both groups
re shown in Table 1. A representative case is shown in Figure 1. There
as a correlation between TE-e= and LVEDP at baseline (r  0.71,
p  0.001) and during LPP (r  0.82, p  0.001). There was also a
relationship between the change in LVEDP in response to LPP and
the change in TE-e= (r  0.50, p  0.001). The TE-e= (standardized
eta 0.73, p 0.001 at baseline and standardized beta 0.89, p
.001 during LPP) was an independent predictor of the LVEDP in
ultivariate regression analysis with adjustment for age and sex. A
OC curve (area under the curve [AUC] 0.93) was used to select a
E-e= cutoff of 38 ms (specificity: 91%; sensitivity: 85%) to predict
levated LVEDP (16 mm Hg) during LPP. For differentiating
levated LVEDP during LPP, the AUC was significantly higher for
he TE-e= compared with E/e= (AUC  0.93 vs. AUC  0.72, p 
.004). The TE-e= (standardized beta 0.42, p 0.011 at baseline and
tandardized beta 0.71, p 0.001 during LPP) were also indepen-
ent predictors of tau in multivariate regression analysis with adjust-
ent for age and sex. The ICC of intraobserver variability was 0.98
p  0.001), and interobserver variability was 0.95 (p  0.001).
This study is the first to demonstrate that single-beat TE-e=
correlated with invasively measured LV diastolic pressure, and that
the TE-e= was a better predictor of LV filling pressure than E/e=. In
addition, our study showed that TE-e= is pre-load–dependent
compared with other Doppler parameters of LV diastolic function.
TE-e= could be influenced by pre-load changes, especially with
impaired LV relaxation.
We postulate that because the mitral E begins with the crossing of
left atrial (LA) and LV pressures, an augmentation of LA pressure
might shorten the time needed for LA and LV pressures to cross, and
this would shorten the isovolumic relaxation time. The onset of e= is
influenced by LV active relaxation and the cardiac restoring forces in
end diastole. As LV relaxation is delayed and early diastolic suction is
reduced, the onset of e= is delayed and follows the onset of the E wave. In
addition, an augmentation in pre-load might prolong the duration of
systole and delay the onset of e=. For these reasons, TE-e=was prolonged by
a pre-load increase. The main limitation of this study was the small
number of patients with elevated LVEDP at baseline (8 of 42).
Elevation of LVEDPprolongs TE-e=, and thismay be due to enhanced
arly diastolic mismatch between mitral inflow and annular motion. TE-e=
is a sensitive noninvasive index for the estimation of LVEDP, and dual
Doppler echocardiography is a practical method for the accurate measure-
ment of this index in a single beat.
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